Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Astera Labs (ALAB) EBITDA Margin (2023 - 2025)

Astera Labs' EBITDA Margin history spans 3 years, with the latest figure at 16.7% for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 203.0% year-over-year to 16.7%, compared with a TTM value of 26.16% through Dec 2025, up 4717.0%, and an annual FY2025 reading of 26.16%, up 4717.0% over the prior year.
  • EBITDA Margin for Q4 2025 was 16.7% at Astera Labs, down from 40.05% in the prior quarter.
  • The five-year high for EBITDA Margin was 40.05% in Q3 2025, with the low at 189.15% in Q2 2023.
  • Average EBITDA Margin over 3 years is 25.18%, with a median of 6.1% recorded in 2024.
  • Biggest YoY gain for EBITDA Margin was 17895bps in 2024; the steepest drop was -4536bps in 2024.
  • Tracing ALAB's EBITDA Margin over 3 years: stood at 29.49% in 2023, then plummeted by -50bps to 14.68% in 2024, then increased by 14bps to 16.7% in 2025.
  • Per Business Quant, the three most recent readings for ALAB's EBITDA Margin are 16.7% (Q4 2025), 40.05% (Q3 2025), and 27.13% (Q2 2025).